BAMBOOSHEALTH (02293) · Company profile · Eqvero

BAMBOOSHEALTH

02293HKEX

Unit: HKD	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	66.48 m HKD	74.4 m HKD	94.79 m HKD	126.56 m HKD	140.3 m HKD
Cost of revenue	37.12 m HKD	34.15 m HKD	36.09 m HKD	50.16 m HKD	50.06 m HKD
Selling, general and administrative expense	1.18 m HKD	569 k HKD	369 k HKD	529 k HKD	1.17 m HKD
Operating profit after depreciation	13.19 m HKD	22.96 m HKD	41.48 m HKD	59.86 m HKD	73.12 m HKD
Operating profit before depreciation	22.32 m HKD	32.21 m HKD	51.62 m HKD	69.85 m HKD	80.8 m HKD
EBIT	13.19 m HKD	22.96 m HKD	41.48 m HKD	59.86 m HKD	73.12 m HKD
EBITDA	22.32 m HKD	32.21 m HKD	51.62 m HKD	69.85 m HKD	80.8 m HKD
Interest expense	2.08 m HKD	3.29 m HKD	2.81 m HKD	1.95 m HKD	775 k HKD
Profit before tax	9.44 m HKD	22.43 m HKD	39.23 m HKD	58.67 m HKD	72.44 m HKD
Income tax expense	3.2 m HKD	4.89 m HKD	8.31 m HKD	11.76 m HKD	13.82 m HKD
Income before extraordinary items	6.24 m HKD	17.54 m HKD	30.92 m HKD	46.92 m HKD	58.62 m HKD
Common dividends	10.06 m HKD	16.1 m HKD	30.14 m HKD	30 m HKD	30 m HKD
Total dividends	10.06 m HKD	16.1 m HKD	30.14 m HKD	30 m HKD	30 m HKD

Quotes are end-of-day data. Content is for research purposes and is not investment advice.